<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02844959</url>
  </required_header>
  <id_info>
    <org_study_id>KB/143/2016</org_study_id>
    <nct_id>NCT02844959</nct_id>
  </id_info>
  <brief_title>Inflammatory Response as a Prognostic Factor of Recurrence of Atrial Fibrillation After Ablation</brief_title>
  <acronym>ACtIVE-AF</acronym>
  <official_title>Assessment of Course of Inflammatory Biomarkers Concentrations After Pulmonary Veins Isolation as a Prognostic Factor of Atrial Fibrillation Treatment Effectiveness (ACtIVE-AF Study)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medical University of Warsaw</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medical University of Warsaw</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to evaluate inflammatory response as a prognostic factor of atrial
      fibrillation recurrency after ablation. Inflammatory response will be assessed by double
      measurement of C-reactive protein, fibroblast growth factor 2 (FGF2), matrix metallopeptidase
      8 (MMP8) and body temperature. Dynamics of change of troponin I will be measured
      additionally.

      After ablation each patient will be monitored with ECG telemonitoring system for 7 days.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>July 2016</start_date>
  <completion_date type="Anticipated">July 2018</completion_date>
  <primary_completion_date type="Anticipated">July 2017</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>6 Months</target_duration>
  <primary_outcome>
    <measure>Atrial fibrillation within the first 7 days after ablation</measure>
    <time_frame>within the first 7 days after ablation</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Atrial fibrillation within 6 months after ablation</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Atrial Fibrillation</condition>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      From each patient 10 ml of venous blood will be collected twice - just before ablation and 24
      hours afterwards - and centrifugated to obtain serum.
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Study includes adult patients qualified for ablation due to atrial fibrillation.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  signed consent;

          -  criteria for ablation of atrial fibrillation.

        Exclusion Criteria:

          -  previous pulmonary veins isolation;

          -  ablation other than pulmonary veins isolation during the procedure;

          -  atrial fibrillation at the beginning of ablation procedure;

          -  usage of 'single shot' devices.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Marcin D Grabowski, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>1st Department of Cardiology Medical University of Warsaw</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Paweł Balsam, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>1st Department of Cardiology Medical University of Warsaw</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Piotr Lodziński, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>1st Department of Cardiology Medical University of Warsaw</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Grzegorz Opolski, Professor</last_name>
    <role>Study Chair</role>
    <affiliation>1st Department of Cardiology Medical University of Warsaw</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Michał Peller, MD</last_name>
    <phone>694 914 962</phone>
    <phone_ext>0048</phone_ext>
    <email>michalpeller@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Krzysztof Ozierański, MD</last_name>
    <phone>509 996 947</phone>
    <phone_ext>0048</phone_ext>
    <email>krzysztof.ozieranski@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>1st Department of Cariology of Medcial University of Warsaw</name>
      <address>
        <city>Warsaw</city>
        <state>Mazowieckie</state>
        <zip>02-097</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michał Peller, MD</last_name>
      <phone>694 914 962</phone>
      <phone_ext>0048</phone_ext>
      <email>michalpeller@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Krzysztof Ozierański, MD</last_name>
      <phone>509 996 947</phone>
      <phone_ext>0048</phone_ext>
      <email>krzysztof.ozieranski@gmail.com</email>
    </contact_backup>
    <investigator>
      <last_name>Michał Peller, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Krzysztof Ozierański, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Paweł Balsam, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Piotr Lodziński, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Marcin D Grabowski, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Grzegorz Opolski, Professor</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Kacper Maciejewski, student</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Poland</country>
  </location_countries>
  <verification_date>July 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 22, 2016</study_first_submitted>
  <study_first_submitted_qc>July 25, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 26, 2016</study_first_posted>
  <last_update_submitted>July 25, 2016</last_update_submitted>
  <last_update_submitted_qc>July 25, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 26, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Medical University of Warsaw</investigator_affiliation>
    <investigator_full_name>Marcin Grabowski</investigator_full_name>
    <investigator_title>Clinical Professor, Marcin Grabowski, Medical University of Warsaw</investigator_title>
  </responsible_party>
  <keyword>Atrial Fibrillation</keyword>
  <keyword>Biomarkers</keyword>
  <keyword>Inflammatory Response</keyword>
  <keyword>C-reactive protein</keyword>
  <keyword>FGF2</keyword>
  <keyword>MMP8</keyword>
  <keyword>troponin I</keyword>
  <keyword>body temperature</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Atrial Fibrillation</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

